# HOPE-CVD-Virtual: A Virtual Trial to Evaluate the Primary Prevention of CVD

> **NCT05827861** · NA · COMPLETED · sponsor: **National University of Singapore** · enrollment: 1121 (actual)

## Conditions studied

- Cardiovascular Diseases

## Interventions

- **BEHAVIORAL:** HeartAge
- **BEHAVIORAL:** HOPE-CVD Mobile App
- **BEHAVIORAL:** Genetic Risk Score

## Key facts

- **NCT ID:** NCT05827861
- **Lead sponsor:** National University of Singapore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-15
- **Primary completion:** 2025-10-10
- **Final completion:** 2025-10-10
- **Target enrollment:** 1121 (ACTUAL)
- **Last updated:** 2026-04-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05827861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05827861, "HOPE-CVD-Virtual: A Virtual Trial to Evaluate the Primary Prevention of CVD". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT05827861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*